Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine

NCT00541736 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2008-05-29

No results posted yet for this study

Summary

The aim of the present study is to explore the importance of migraine genes on the headache/migraine responses after GTN in FHM-patients and healthy volunteers.

Conditions

  • Familial Hemiplegic Migraine

Interventions

DRUG

Nitroglycerine

Nitroglycerine infusion over 20 minutes: 0.5 ug/kg/min

Sponsors & Collaborators

  • EUROHEAD

    collaborator OTHER
  • Danish Headache Center

    lead OTHER

Principal Investigators

  • Jakob Møller Hansen, MD · Danish Headache Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2008-05-31
Completion
2008-05-31

Countries

  • Denmark

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00541736 on ClinicalTrials.gov